Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Research · June 12, 2024

Twenty Serum Protein Biomarkers Could Aid Characterization of MS Disease Activity

Nature Communications


Additional Info

Disclosure statements are available on the authors' profiles:

Nature Communications
Inflammatory and neurodegenerative serum protein biomarkers increase sensitivity to detect clinical and radiographic disease activity in multiple sclerosis
Nat Commun 2024 May 20;[EPub Ahead of Print], T Chitnis, F Qureshi, VM Gehman, M Becich, R Bove, BAC Cree, R Gomez, SL Hauser, RG Henry, A Katrib, H Lokhande, A Paul, SJ Caillier, A Santaniello, N Sattarnezhad, S Saxena, H Weiner, H Yano, SE Baranzini

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading